Markus Schwaiger Selected Research

Integrin alphaVbeta3

12/2009	Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.
7/2009	Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
12/2008	Imaging of integrin alphavbeta3 expression.
9/2008	In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction.
5/2008	Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography.
4/2008	Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.
2/2008	Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET.
1/2008	Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
3/2005	Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD.
1/2004	[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Schwaiger Research Topics

Disease

140	Neoplasms (Cancer) 01/2022 - 09/2002
57	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 08/2005
37	Myocardial Infarction 10/2022 - 03/2002
29	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2002
20	Infarction (Infarctions) 01/2018 - 06/2002
15	Carcinoma (Carcinomatosis) 01/2019 - 02/2003
13	Inflammation (Inflammations) 01/2020 - 08/2002
11	Breast Neoplasms (Breast Cancer) 04/2020 - 02/2008
10	Glioma (Gliomas) 01/2021 - 11/2002
10	Lymphoma (Lymphomas) 12/2020 - 06/2007
10	Adenocarcinoma 01/2019 - 12/2005
10	Stomach Neoplasms (Stomach Cancer) 11/2011 - 12/2003
9	Hypoxia (Hypoxemia) 09/2019 - 07/2004
8	Atherosclerotic Plaque (Atheroma) 01/2021 - 05/2005
7	Alzheimer Disease (Alzheimer's Disease) 05/2015 - 07/2006
6	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 09/2009
6	Lymphatic Metastasis 01/2019 - 08/2005
6	ST Elevation Myocardial Infarction 04/2016 - 06/2005
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2013 - 10/2002
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 12/2011
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 06/2006
5	Head and Neck Neoplasms (Head and Neck Cancer) 03/2017 - 08/2005
5	Rectal Neoplasms (Rectal Cancer) 06/2014 - 06/2002
4	Glioblastoma (Glioblastoma Multiforme) 09/2019 - 11/2002
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 10/2005
4	Necrosis 01/2017 - 02/2011
4	Stroke (Strokes) 02/2016 - 02/2004
4	Heart Failure 10/2015 - 10/2004
4	Cicatrix (Scar) 06/2015 - 01/2002
4	Amyloid Plaque 09/2011 - 03/2007
4	Meningioma (Meningiomas) 11/2008 - 08/2003
3	Pheochromocytoma 01/2021 - 01/2011
3	Ventricular Remodeling 01/2021 - 02/2012
3	Atherosclerosis 01/2021 - 03/2011
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 05/2011

Drug/Important Bio-Agent (IBA)

35	AntigensIBA 01/2021 - 08/2007
32	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2002
28	LigandsIBA 01/2021 - 09/2002
22	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2020 - 12/2005
16	IntegrinsIBA 01/2021 - 05/2008
16	gallium 68 PSMA-11IBA 12/2018 - 08/2015
13	Biological ProductsIBA 01/2019 - 08/2005
13	Choline (Choline Chloride)IBA 12/2017 - 08/2005
12	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2005
12	Peptides (Polypeptides)IBA 11/2018 - 01/2002
10	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2005
10	Chemokine ReceptorsIBA 12/2020 - 10/2005
10	Integrin alphaVbeta3IBA 12/2009 - 01/2004
9	68Ga-pentixaforIBA 12/2020 - 01/2015
8	Pyruvic Acid (Pyruvate)IBA 01/2021 - 07/2013
8	PSMA I&TIBA 01/2019 - 08/2015
7	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 07/2013
7	Amyloid (Amyloid Fibrils)IBA 10/2020 - 02/2011
7	Amino Acids FDA Link 01/2020 - 06/2002
7	sodium-iodide symporter (sodium iodide symporter)IBA 10/2019 - 08/2013
7	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 07/2017 - 05/2016
7	GadoliniumIBA 06/2015 - 01/2002
7	ThymidineIBA 01/2014 - 05/2008
7	Integrin beta3 (GPIIIa)IBA 12/2009 - 01/2004
7	Glycoproteins (Glycoprotein)IBA 04/2009 - 03/2002
6	Radioisotopes (Radionuclides)IBA 01/2021 - 02/2002
6	Methionine (L-Methionine)FDA Link 11/2011 - 06/2002
6	Abciximab (ReoPro)FDA Link 04/2009 - 03/2002
5	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 08/2007
5	AntibodiesIBA 09/2019 - 09/2003
5	Pharmaceutical PreparationsIBA 01/2018 - 06/2007
5	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2017 - 06/2007
5	AcidsIBA 09/2015 - 02/2007
5	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2011 - 09/2002
5	Monoclonal AntibodiesIBA 02/2010 - 09/2003
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 07/2013
4	Galectin 3 (LGALS3)IBA 01/2021 - 01/2016
4	Contrast MediaIBA 03/2020 - 01/2010
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 01/2016
4	Peptide Receptors (Peptide Receptor)IBA 02/2018 - 01/2002
4	Rituximab (Mabthera)FDA Link 06/2014 - 10/2002
4	alovudineIBA 01/2013 - 06/2007
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2011 - 01/2002
4	octadeca(lysine)IBA 03/2009 - 05/2004
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022 - 12/2016
3	Mannose ReceptorIBA 01/2022 - 12/2017
3	ApolipoproteinsIBA 01/2021 - 12/2017
3	EnzymesIBA 01/2021 - 03/2007
3	Apolipoproteins E (ApoE)IBA 01/2021 - 12/2017
3	3-Iodobenzylguanidine (Iobenguane)IBA 01/2021 - 01/2004

Therapy/Procedure

83	Therapeutics 01/2022 - 06/2002
21	Drug Therapy (Chemotherapy) 01/2018 - 07/2003
19	Radiotherapy 10/2019 - 01/2002
14	Precision Medicine 12/2020 - 08/2013
10	Neoadjuvant Therapy 09/2016 - 10/2005
10	Percutaneous Coronary Intervention 04/2016 - 02/2004
8	Castration 01/2019 - 08/2015
7	Chemoradiotherapy 01/2018 - 06/2002
7	Radioimmunotherapy 06/2013 - 09/2003
6	Stents 03/2011 - 02/2003
5	Prostatectomy (Retropubic Prostatectomy) 01/2019 - 01/2016
4	Immunotherapy 01/2022 - 06/2007
4	Intravenous Injections 01/2020 - 09/2015
4	Cystectomy 01/2018 - 06/2006
4	Lymph Node Excision (Lymph Node Dissection) 01/2017 - 06/2006